A Proposed Nomogram Model for Recurrence of Non-Muscle Invasive Bladder Carcinoma COMMENT

被引：0
|
作者：
Tsapakidis, Konstantinos [1 ]
Liontos, Michalis [2 ]
Tolia, Maria [3 ]
Tsoukalas, Nikolaos [4 ]
机构：
[1] Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Oncol, Larisa, Greece
[2] Natl & Kapodistrian Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[3] Univ Crete, Sch Med, Dept Radiotherapy, Iraklion, Greece
[4] 401 Gen Mil Hosp Athens, Dept Oncol, Gennimata N 10-12 Ampelokipi, Athens 11524, Greece
来源：
JOURNAL OF INVESTIGATIVE SURGERY | 2022年 / 35卷 / 07期
关键词：
EORTC RISK TABLES; PROGRESSION;
D O I：
10.1080/08941939.2022.2071507
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1610 / 1611
页数：2
相关论文
共 50 条
  • [41] Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
    Xu, Hao
    Xie, Linguo
    Liu, Xiaoteng
    Zhang, Yu
    Shen, Zhonghua
    Chen, Tao
    Qiu, Xiaoyu
    Sha, Nan
    Xing, Chen
    Wu, Zhouliang
    Hu, Hailong
    Wu, Changli
    [J]. ONCOLOGY LETTERS, 2017, 14 (03) : 3522 - 3528
  • [42] Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer
    S. Singer
    C. Ziegler
    T. Schwalenberg
    A. Hinz
    H. Götze
    T. Schulte
    [J]. Supportive Care in Cancer, 2013, 21 : 1383 - 1393
  • [43] Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer
    Singer, S.
    Ziegler, C.
    Schwalenberg, T.
    Hinz, A.
    Goetze, H.
    Schulte, T.
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1383 - 1393
  • [44] Association of BCG shortage with bladder cancer recurrence in high-risk non-muscle invasive bladder cancer
    Lee, Sangmin
    Lim, Bumjin
    You, Dalsan
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    Jeong, In Gab
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 26 - 27
  • [45] INTRAVESICAL CHEMOTHERAPY VERSUS CONTINUOUS BLADDER IRRIGATION FOR PREVENTION OF SINGLE, NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE
    Toniolo, Jason T.
    Huang, Dora
    Sengupta, Shomik
    Bolton, Damien M.
    Lawrentschuk, Nathan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 60
  • [46] Active Surveillance for non-muscle invasive Bladder Cancer
    Lorenz, Judith
    [J]. AKTUELLE UROLOGIE, 2024, 55 (04)
  • [47] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    [J]. INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [48] Immune Therapies in Non-Muscle Invasive Bladder Cancer
    Ho, Philip L.
    Williams, Stephen B.
    Kamat, Ashish M.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (02)
  • [49] Valrubicin in refractory non-muscle invasive bladder cancer
    Sharma, Pranav
    Zargar-Shoshtari, Kamran
    Sexton, Wade J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (12) : 1379 - 1387
  • [50] ABLASTIC TUR IN NON-MUSCLE INVASIVE BLADDER CANCER
    Voldohin, Alexander
    Levchenko, Vyacheslav
    Aiman, Abu Trabi
    Idalov, Aub
    [J]. JOURNAL OF ENDOUROLOGY, 2012, 26 : A89 - A89
12345